首页> 外文期刊>Diabetic medicine: A journal of the British Diabetic Association >Predictive performance of a genetic risk score using 11 susceptibility alleles for the incidence of Type 2 diabetes in a general Japanese population: a nested case–control study
【24h】

Predictive performance of a genetic risk score using 11 susceptibility alleles for the incidence of Type 2 diabetes in a general Japanese population: a nested case–control study

机译:使用11型易感性等位基因的遗传风险评分的预测性能,用于一般日本人群中2型糖尿病的发病率:嵌套病例对照研究

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract Aims To assess the predictive ability of a genetic risk score for the incidence of Type 2 diabetes in a general Japanese population. Methods This prospective case–control study, nested within a Japan Public Health Centre‐based prospective study, included 466 participants with incident Type 2 diabetes over a 5‐year period (cases) and 1361 control participants, as well as 1463 participants with existing diabetes and 1463 control participants. Eleven susceptibility single nucleotide polymorphisms, identified through genome‐wide association studies and replicated in Japanese populations, were analysed. Results Most single nucleotide polymorphism loci showed directionally consistent associations with diabetes. From the combined samples, one single nucleotide polymorphism (rs2206734 at CDKAL 1 ) reached a genome‐wide significance level (odds ratio 1.28, 95% CI 1.18–1.40; P = 1.8 × 10 –8 ). Three single nucleotide polymorphisms (rs2206734 in CDKAL 1 , rs2383208 in CDKN 2A/B , and rs2237892 in KCNQ 1 ) were nominally significantly associated with incident diabetes. Compared with the lowest quintile of the total number of risk alleles, the highest quintile had a higher odds of incident diabetes (odds ratio 2.34, 95% CI 1.59–3.46) after adjusting for conventional risk factors such as age, sex and BMI . The addition to the conventional risk factor‐based model of a genetic risk score using the 11 single nucleotide polymorphisms significantly improved predictive performance; the c‐statistic increased by 0.021, net reclassification improved by 6.2%, and integrated discrimination improved by 0.003. Conclusions Our prospective findings suggest that the addition of a genetic risk score may provide modest but significant incremental predictive performance beyond that of the conventional risk factor‐based model without biochemical markers.
机译:摘要旨在评估遗传风险评分的预测能力,用于日本一般人群中2型糖尿病发病率。方法采用这项前瞻性病例对照研究,嵌套在日本公共卫生中心的前瞻性研究中,包括466名参与者在5年内(案例)和1361名控制参与者,以及1463名患有现有糖尿病的参与者和1463个控制参与者。分析了通过基因组关联研究鉴定的单一核苷酸多态性,并在日本群体中鉴定。结果大多数单一核苷酸多态性基因座与糖尿病呈向定向一致。从组合的样品中,一种单一核苷酸多态性(CDKAL 1的RS2206734)达到了基因组 - 宽的显着性水平(差距1.28,95%CI 1.18-1.40; P = 1.8×10 -8)。三种单一核苷酸多态性(CDKAL 1,RS22383208的CDKN 2a / b中的RS2206734,KCNQ 1的RS2237892)被称为与入射糖尿病有关。与风险等位基因总数的最低五分之比相比,在调整年龄,性别和BMI等常规风险因素的情况下,最高宾列赛的最高型糖尿病患者的含量较高(差距2.34,95%CI 1.59-3.46)。使用11个单核苷酸多态性的遗传风险评分的常规风险因子的基于遗传风险评分的增分显着提高了预测性能; C统计量增加0.021,净重新分类提高了6.2%,综合歧视提高了0.003。结论我们的前瞻性研究结果表明,添加遗传风险评分可以提供超出常规风险因素的模型的适度但显着的增量预测性能,没有生物化学标记。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号